BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.

Lieke LanjouwMarian J E MouritsJoost BartArja Ter ElstLieke P V BergerAnnemieke H van der HoutNaufil AlamGeertruida H de Bock

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)

testing in all patients with epithelial ovarian cancer. Suboptimal testing rates limit optimization of care for patients with epithelial ovarian cancer and counseling of potentially affected relatives.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
healthcare
peritoneal dialysis
palliative care
prognostic factors
quality improvement
patient reported outcomes
chronic pain
hiv infected
hiv testing